Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study.

Serum prostate specific antigen is a strong predictor of future prostate growth in men with... We analyze patterns of prostate growth in men diagnosed with benign prostatic hyperplasia (BPH) and treated with placebo during 4 years, and determine which baseline parameters were the strongest predictors of growth. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Journal of urology Pubmed

Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study.

Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study.


Abstract

We analyze patterns of prostate growth in men diagnosed with benign prostatic hyperplasia (BPH) and treated with placebo during 4 years, and determine which baseline parameters were the strongest predictors of growth.

Loading next page...
 
/lp/pubmed/serum-prostate-specific-antigen-is-a-strong-predictor-of-future-0XPaWWhkBB

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0022-5347
pmid
10604304

Abstract

We analyze patterns of prostate growth in men diagnosed with benign prostatic hyperplasia (BPH) and treated with placebo during 4 years, and determine which baseline parameters were the strongest predictors of growth.

Journal

The Journal of urologyPubmed

Published: Jan 27, 2000

There are no references for this article.